Loading market dashboard
Hikma Pharmaceuticals PLC
HKMPYHealthcareOTCGB
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
LONDON, June 4, 2026 /PRNewswire/ -- Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc., (Hikma) offered the following comments on today's unanimous decision by the Supreme Court of the United States effectively ending Amarin's patent infringement litigation against the company. "Hikma has long fought for patients and their access to safe, high-quality, and affordable medicines," said Sam Park, General Counsel, Hikma.
Cleveland and Columbus, Ohio, June 01, 2026 (GLOBE NEWSWIRE) -- COLUMBUS and CLEVELAND, Ohio - Ohio Governor Mike DeWine, along with Hikma Pharmaceuticals, JobsOhio, the City of Bedford, and other state and local partners, today announced plans for a significant expansion of Hikma's manufacturing operations in Ohio, reinforcing the company's commitment to the state's growing pharmaceutical and biomanufacturing industry.
Hikma Pharmaceuticals PLC (HKMPY) Sales/ Trading Statement Call Transcript
Hikma Pharmaceuticals reiterated its 2026 guidance on Thursday, adding that, while it has faced some pressure on shipping, energy, and insurance costs due to the war in the Middle East, a key market for the firm, it was confident it could absorb the higher costs.
